• Approved News

Bristol-Myers Squibb Co：Mezigdomide formally included in the priority review and approval procedure.

• Drug news

How much does Dovato (Lamivudine and Dolutegravir Sodium Tablets) Cost& price without insurance in China?

• Drug development

Eli Lilly’s GLP-1R/GIPR/GCGR agonist achieves success in Phase III weight loss study

• Drug news

How much does Biktarvy (Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets) Cost& price without insurance in China?

• Drug development

Lepu Biopharma: The world’s first GPC3 ADC to publish clinical results achieves clinical breakthrough in liver cancer

• Drug development

BMS: Mezigdomide capsule included in priority review

• Drug development

PROZIN PHARMACEUTICAL’s Category 1.2 New Traditional Chinese Medicine Drug Xiuqiu Zonggan Tablets and Extract Received CDE Clinical Trial Permission

• Drug development

CSPC: BCMA/CD19 CAR-T approved for clinical trials

• Drug development

Innovent’s B7-H3/EGFR bispecific antibody ADC receives clinical trial approval

• Drug news

How much does Epclusa (Sofosbuvir and Velpatasvir Tablets) Cost& price without insurance in China?

• Drug news

How much does Harvoni (Ledipasvir and Sofosbuvir Tablets) Cost& price without insurance in China?

• Drug news

How much does Ganovo (Danoprevir Sodium Tablets) Cost& price without insurance in China?